Predictive genomic markers of response to VEGF targeted therapy (TT) in metastatic renal cell carcinoma (mRCC): Role of VHL and TP53 mutation, and FLT1 germline variant - 100098

Spotlight
Video

Predictive genomic markers of response to VEGF targeted therapy (TT) in metastatic renal cell carcinoma (mRCC): Role of VHL and TP53 mutation, and FLT1 germline variant

kidneycancer has 425 videos Subscribe Here

Loading........
Description: Andrew W. Hahn, MD University of Utah Huntsman Cancer Institute
@onchahn discusses Predictive genomic markers of response to VEGF targeted therapy (TT) in metastatic renal cell carcinoma (mRCC): Role of VHL and TP53 mutation, and FLT1 germline variant
Shared By : kidneycancer
Posted on : 11/07/17
Added : 3 months ago
Category : Kidney Cancer



Recommended

Nothing found.